UnitedHealth Group Incorporated (NYSE:UNH) Shares Purchased by Vanguard Capital Wealth Advisors

Vanguard Capital Wealth Advisors increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 13,722 shares of the healthcare conglomerate’s stock after purchasing an additional 48 shares during the period. UnitedHealth Group accounts for about 5.8% of Vanguard Capital Wealth Advisors’ holdings, making the stock its 3rd biggest holding. Vanguard Capital Wealth Advisors’ holdings in UnitedHealth Group were worth $7,224,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of UNH. Bray Capital Advisors boosted its stake in UnitedHealth Group by 0.5% during the third quarter. Bray Capital Advisors now owns 9,616 shares of the healthcare conglomerate’s stock worth $4,848,000 after buying an additional 50 shares during the period. Bridge Advisory LLC boosted its stake in shares of UnitedHealth Group by 12.8% in the third quarter. Bridge Advisory LLC now owns 662 shares of the healthcare conglomerate’s stock valued at $334,000 after purchasing an additional 75 shares during the period. Valeo Financial Advisors LLC boosted its stake in shares of UnitedHealth Group by 20.5% in the third quarter. Valeo Financial Advisors LLC now owns 14,018 shares of the healthcare conglomerate’s stock valued at $7,068,000 after purchasing an additional 2,382 shares during the period. Mason & Associates Inc boosted its stake in shares of UnitedHealth Group by 8.4% in the third quarter. Mason & Associates Inc now owns 3,263 shares of the healthcare conglomerate’s stock valued at $1,645,000 after purchasing an additional 252 shares during the period. Finally, Mitchell Mcleod Pugh & Williams Inc. boosted its stake in shares of UnitedHealth Group by 1.5% in the third quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 8,735 shares of the healthcare conglomerate’s stock valued at $4,404,000 after purchasing an additional 129 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Stock Performance

NYSE:UNH traded down $5.33 during midday trading on Tuesday, reaching $483.70. The stock had a trading volume of 3,366,438 shares, compared to its average volume of 4,466,545. The stock has a market cap of $445.04 billion, a P/E ratio of 29.63, a P/E/G ratio of 1.43 and a beta of 0.54. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $554.70. The firm has a fifty day simple moving average of $485.19 and a two-hundred day simple moving average of $513.81. The company has a quick ratio of 0.79, a current ratio of 0.85 and a debt-to-equity ratio of 0.69.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, topping the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The business had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. During the same period in the previous year, the firm earned $6.26 EPS. The business’s revenue for the quarter was up 8.6% compared to the same quarter last year. On average, equities analysts expect that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were paid a $1.88 dividend. This represents a $7.52 annualized dividend and a yield of 1.55%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s payout ratio is 45.97%.

Analyst Upgrades and Downgrades

UNH has been the subject of a number of recent research reports. Wells Fargo & Company decreased their price target on shares of UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a research note on Monday, April 8th. Erste Group Bank reiterated a “hold” rating on shares of UnitedHealth Group in a research note on Wednesday, March 13th. Truist Financial reiterated a “buy” rating and issued a $600.00 price target on shares of UnitedHealth Group in a research note on Wednesday, April 17th. Barclays lifted their price target on shares of UnitedHealth Group from $534.00 to $560.00 and gave the stock an “overweight” rating in a research note on Wednesday, April 17th. Finally, Royal Bank of Canada cut their price objective on shares of UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating on the stock in a report on Wednesday, April 17th. Four investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. According to MarketBeat, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and a consensus price target of $570.05.

Insider Activity at UnitedHealth Group

In related news, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the sale, the executive vice president now owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the transaction, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by corporate insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.